California-based technology-enabled service company FirstVitals Health and Wellness has received a non-invasive technology, designed for diagnosis of diabetic neuropathy, from NeuroMetrix to supplement its Centers for Medicare and Medicaid ...
Tags: NeuroMetrix, diagnostic technology, FirstVitals Health
Wireless remote monitoring devices will be used by more than 1.8 million people worldwide in four years, representing a six-fold increase in adoption of telehealth technology, according to a new study by InMedica, part of research firm IHS. ...
The Siemens Healthcare Diagnostics DCA HbA1c test kit, already widely used to monitor diabetes patients’ HbA1c levels, has achieved the CE mark as an aid to diagnose diabetes and identify patients at risk from developing the disease. ...
Tags: CE mark, DCA HbA1c test kit, diabetes, Siemens
OneSource Medical Group in Florida has entered into an agreement to distribute NeuroMetrix's transcutaneous electrical nerve stimulator, designed to help manage chronic pain in diabetes patients with painful diabetic neuropathy. The ...
Tags: OneSource, agreement, NeuroMetrix
Dexcom has obtained CE mark approval for its new Dexcom G4 continuous blood glucose monitoring system. The Dexcom G4 system is designed to help diabetes patients to better manage their diabetes and control their glucose levels. Dexcom ...
Tags: Dexcom, CE mark approval, G4 system, diabetes, glucose levels
The FDA has granted orphan drug designation for Andromeda Biotech's DiaPep277 to treat type 1 diabetes (T1D) patients with residual beta cell function. The orphan drug status offers seven years marketing exclusivity from the time of ...
Tags: DiaPep277, type 1 diabetes, T1D, residual beta cell
Furiex Pharmaceuticals said Takeda Global Research & Development Center has resubmitted New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for alogliptin and fixed-dose combination therapy alogliptin and pioglitazone ...
Tags: Furiex Pharmaceuticals, NDAs, alogliptin and pioglitazone
Diabetes patients using Hypurin Porcine Isophane insulin cartridges have been urged to check their medication is correct by the Medicines and Healthcare products Regulatory Agency (MHRA) after a packaging error came to light The issue ...
Tags: diabetes patients, packaging error, carton for cartridges
Abbott has received CE mark approval for Architect HbA1c assay, designed to monitor treatment efficacy for diabetes patients. The chemiluminescent microparticle Architect HbA1c assay, which is designed for the quantitative determination ...
Tags: Architect HbA1c assay, Architect i immunoassay systems
Medtronic has presented two years of follow-up study results of its Resolute drug-eluting stent (DES). The study, which enrolled 878 standard risk2 diabetes patients and 1,903 patients without diabetes, will compare the clinical ...
The FDA has approved Novo Nordisk Levemir (insulin detemir [rDNA origin] injection) for use in children with type 1 diabetes. The basal insulin analog is approved for type 1 diabetes patients from age two through adulthood and adult ...
Tags: FDA, Levemir, treatment for type 1 diabetes